Imnm Price prediction

**Immunome's stock price is difficult to predict with certainty due to the lack of certain key financial data.** Here's an analysis based on the provided information: 1. **Analyst Ratings and Price Targets**: The consensus rating for Immunome is a "Buy," with an average price target of $29.00. This suggests that analysts are generally positive on the stock's future performance. 2. **Recent Trading Activity**: The stock has experienced a significant drop in short interest, which could indicate a potential reversal in sentiment. However, this alone does not guarantee an increase in stock price. 3. **Market Conditions**: The broader market conditions, including sector performance and overall economic indicators, can significantly impact stock prices. It's important to consider these factors when making predictions. 4. **Company Fundamentals**: As mentioned earlier, critical data such as revenue growth rate, ROE, and debt-to-equity ratio are not provided. Obtaining this information would be essential for a more accurate prediction. In conclusion, while the analyst ratings and price targets are positive, the lack of key financial data prevents a conclusive price prediction. Investors should consider obtaining the missing fundamental data and monitoring market conditions to make a more informed decision.